
The rate-limiting enzyme to catabolize 5-fluorouracil (5-FU) is dihydropyrimidine dehydrogenase (DPD), which expression in cancerous tissue is reported to have a relation with anti-tumor effect for 5-FU. In this study, we evaluated the immunohistochemical expression in gastric cancer using two different kinds of anti-human DPD antibody, KM1915 and KM1919. However, recognition of both antibody was mimetic in human gastric cancer, and strong expression of DPD was observed in the interstitial tissue when using KM1919. There is a positive relationship between immunohistochemical expression by KM1915 and mRNA expression in human gastric cancer. Immunohistochemical study with KM1915 might be a clinically useful method to evaluate the expression of DPD in paraffin-embedded materials.
Male, Antibodies, Monoclonal, Middle Aged, Immunohistochemistry, Stomach Neoplasms, Tumor Cells, Cultured, Humans, Female, RNA, Messenger, Oxidoreductases, Dihydrouracil Dehydrogenase (NADP), Aged
Male, Antibodies, Monoclonal, Middle Aged, Immunohistochemistry, Stomach Neoplasms, Tumor Cells, Cultured, Humans, Female, RNA, Messenger, Oxidoreductases, Dihydrouracil Dehydrogenase (NADP), Aged
| citations The total number of citations received by all articles of the researcher of interest. | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
